Wall Street takes stock of biotechnology

Crawford, Mark
November 1991
New Scientist;11/23/91, Vol. 132 Issue 1796, p36
Discusses investment prospects in the biotechnology sector. Interest of financial investors in the business of genetic engineering; Stimuli for the influx of investments in U.S. biotechnology stocks; Profitability of biotechnology companies; Prediction of an increase in the number of biotechnology firms in the U.S.; Increase in stock prices of some biotechnology holdings in 1990.


Related Articles

  • International stem Cell Using New Funding to Retire Debt. Chambers, Heather // San Diego Business Journal;1/5/2009, Vol. 30 Issue 1, p11 

    The article reports on the move of International Stem Cell Corp., a company that derives human stem cell lines from unfertilized human eggs, to use a new funding to retire its secured debt. Kenneth Aldrich, chief executive officer of the International Stem Cell Corp., notes that the move is a...

  • VITAL SIGNS.  // BioWorld Today;3/29/2010, Vol. 21 Issue 59, p2 

    A chart is presented that shows the amount of money raised by biotech firms in 2009 and 2010.

  • Financings Roundup.  // BioWorld Today;8/20/2013, Vol. 24 Issue 159, p2 

    The article presents an update on the financing efforts of biotechnology companies as of August 20, 2013, including the move by Genspera Inc. to sign subscription agreements with accredited investors and qualified institutional buyers totaling approximately 5 million U.S. dollars.

  • Financings Roundup.  // BioWorld Today;4/13/2011, Vol. 22 Issue 71, p2 

    This section offers news briefs related to financing in the biotechnology industry, including the investment of Conatos Pharmaceuticals Inc. in MPM Capital, the overallotment option of underwriters in the public offering of Inhibitex and the share placement of Living Cell Technologies Ltd.

  • Life sciences initiative seeks seed capital. Schnitzler, Peter // Indianapolis Business Journal;3/31/2003, Vol. 24 Issue 3, p21A 

    Reports on the establishment of Indiana's Future Fund, a venture capital fund for the state's biotechnology companies. Goals institutional investors can achieve by participating in the fund; Benefits to and transformation of the state economy; Role of the Central Indiana Life Sciences Initiative.

  • Biotech deals.  // Indianapolis Business Journal;3/19/2007 BioFutures Supplement, Vol. 28, p34 

    The article reports on the results of the PriceWaterhouseCoopers MoneyTree TM Survey of biotechnology investments in Indiana. It defines biotechnology as developers of technology promoting drug development, disease treatment and a deeper understanding of living organisms. Data showed that the...

  • When Funds Flow. MEILING, BRITTANY // San Diego Business Journal;9/15/2014, Vol. 35 Issue 37, p15 

    The article presents a report from professional services network PricewaterhouseCoopers LLC shows the $222.4 million invested by venture capitalists in 26 deals in the second quarter of 2014 with $146 million invested directly in local biotechnology firms in San Diego, California.

  • Financings Roundup.  // BioWorld Today;7/11/2011, Vol. 22 Issue 132, p2 

    This section offers news briefs on financing deals in the biotechnology sector including the equity investment made by Richard M. Schulze Family Foundation on Northwest Biotherapeutics Inc., additional funds secured by SpringLeaf Therapeutics Inc. in a second closing of its Series B financing...

  • Pension plans dally with biotech. Ransom, John // Nature Biotechnology;Jun2006, Vol. 24 Issue 6, p600 

    The article reports on the changing trend of investments on biotechnology private equity by pension managers in Australia and Canada. The reluctance of managers in putting large amount of investment on private equity is changing because of high-rewards from investments in mid-stage biotechnology...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics